3.3 Access to prophylactic and on-demand therapy
Eight out of 64 patients were diagnosed before their first attacks, so
they were not asked to fill out a questionnaire about LTP and ODT.
Thirty-eight patients (67.8%) answered the questionnaire about therapy.
Only 9 patients used Danazol as prophylactic therapy, 1 used tranexamic
acid.
Data about ODT used for the treatment of HAE attacks were collected in
17 patients. Only 6 patients (35.3%) were treated with appropriate
drugs (2 with Icatibant or C1-INH concentrate and 4 with fresh frozen
plasma infusion); eleven patients (64.7%) were treated with ineffective
drugs for the disease: antihistamine (2 patients), steroid (4 patients),
tranexamic acid (5 patients) (Table 3).